Aehr Total Permanent Equity vs Net Working Capital Analysis
AEHR Stock | USD 16.29 1.16 7.67% |
Aehr Test financial indicator trend analysis is way more than just evaluating Aehr Test Systems prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aehr Test Systems is a good investment. Please check the relationship between Aehr Test Total Permanent Equity and its Net Working Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
Total Permanent Equity vs Net Working Capital
Total Permanent Equity vs Net Working Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aehr Test Systems Total Permanent Equity account and Net Working Capital. At this time, the significance of the direction appears to have weak relationship.
The correlation between Aehr Test's Total Permanent Equity and Net Working Capital is 0.35. Overlapping area represents the amount of variation of Total Permanent Equity that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Aehr Test Systems, assuming nothing else is changed. The correlation between historical values of Aehr Test's Total Permanent Equity and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Permanent Equity of Aehr Test Systems are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Total Permanent Equity i.e., Aehr Test's Total Permanent Equity and Net Working Capital go up and down completely randomly.
Correlation Coefficient | 0.35 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Total Permanent Equity
Net Working Capital
Most indicators from Aehr Test's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aehr Test Systems current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aehr Test Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. At this time, Aehr Test's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 12/26/2024, Enterprise Value Multiple is likely to grow to 26.50, though Tax Provision is likely to grow to (19.7 M).
2021 | 2022 | 2023 | 2024 (projected) | |
Gross Profit | 23.7M | 32.7M | 32.5M | 34.2M |
Total Revenue | 50.8M | 65.0M | 66.2M | 69.5M |
Aehr Test fundamental ratios Correlations
Click cells to compare fundamentals
Aehr Test Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Aehr Test fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.6M | 21.7M | 62.3M | 98.1M | 127.9M | 134.3M | |
Other Current Liab | 1.4M | 1.4M | 2.7M | 4.8M | 4.1M | 4.4M | |
Total Current Liabilities | 3.9M | 9.1M | 11.0M | 16.3M | 10.5M | 7.0M | |
Total Stockholder Equity | 14.1M | 11.4M | 51.0M | 75.6M | 111.6M | 117.2M | |
Property Plant And Equipment Net | 2.8M | 2.3M | 2.1M | 8.9M | 9.0M | 9.4M | |
Net Debt | (1.5M) | 241K | (30.5M) | (23.8M) | (43.0M) | (40.8M) | |
Retained Earnings | (74.3M) | (76.3M) | (66.9M) | (52.3M) | (19.2M) | (20.1M) | |
Accounts Payable | 945K | 2.9M | 4.2M | 9.2M | 5.3M | 5.6M | |
Cash | 5.4M | 4.6M | 31.5M | 30.1M | 49.2M | 51.6M | |
Non Current Assets Total | 2.9M | 2.5M | 2.3M | 9.1M | 30.1M | 31.6M | |
Non Currrent Assets Other | 73K | 118K | 121K | 81K | 304K | 288.8K | |
Cash And Short Term Investments | 5.4M | 4.6M | 31.5M | 47.9M | 49.2M | 51.6M | |
Net Receivables | 3.7M | 5.2M | 12.9M | 16.6M | 10.0M | 5.4M | |
Common Stock Shares Outstanding | 22.9M | 23.5M | 27.8M | 29.2M | 29.6M | 31.1M | |
Liabilities And Stockholders Equity | 20.6M | 21.7M | 62.3M | 98.1M | 127.9M | 134.3M | |
Non Current Liabilities Total | 2.7M | 1.2M | 325K | 6.2M | 5.8M | 6.1M | |
Inventory | 8.0M | 8.8M | 15.1M | 23.9M | 37.5M | 39.3M | |
Other Current Assets | 512K | 1.1M | 1.2M | 621K | 1.2M | 899.3K | |
Other Stockholder Equity | 85.9M | 87.6M | 117.7M | 127.8M | 130.6M | 137.1M | |
Total Liab | 6.5M | 10.2M | 11.3M | 22.5M | 16.3M | 8.6M | |
Property Plant And Equipment Gross | 2.8M | 2.3M | 2.1M | 8.9M | 14.0M | 14.7M | |
Total Current Assets | 17.7M | 19.2M | 60.0M | 89.0M | 97.8M | 102.7M | |
Accumulated Other Comprehensive Income | 2.2M | (28K) | (105K) | (155K) | (158K) | (150.1K) | |
Current Deferred Revenue | 170K | 189K | 2.4M | 2.8M | 97K | 92.2K | |
Common Stock Total Equity | 221K | 227K | 231K | 237K | 272.6K | 286.2K | |
Common Stock | 231K | 237K | 271K | 285K | 289K | 147.2K | |
Other Liab | 22K | 148K | 113K | 72K | 64.8K | 61.6K | |
Other Assets | 153K | 198K | 201K | 231K | 207.9K | 380.5K | |
Property Plant Equipment | 2.8M | 2.3M | 2.1M | 8.9M | 10.2M | 10.7M | |
Net Tangible Assets | 14.1M | 11.4M | 51.0M | 75.6M | 86.9M | 91.3M | |
Retained Earnings Total Equity | (66.2M) | (71.5M) | (74.3M) | (76.3M) | (68.7M) | (72.1M) | |
Capital Surpluse | 85.9M | 87.6M | 117.7M | 127.8M | 146.9M | 85.6M | |
Deferred Long Term Liab | 522K | 342K | 22K | 99K | 113.9K | 173.1K |
Pair Trading with Aehr Test
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aehr Test position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aehr Test will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Aehr Test could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aehr Test when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aehr Test - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aehr Test Systems to buy it.
The correlation of Aehr Test is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aehr Test moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aehr Test Systems moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aehr Test can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Aehr Stock Analysis
When running Aehr Test's price analysis, check to measure Aehr Test's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aehr Test is operating at the current time. Most of Aehr Test's value examination focuses on studying past and present price action to predict the probability of Aehr Test's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aehr Test's price. Additionally, you may evaluate how the addition of Aehr Test to your portfolios can decrease your overall portfolio volatility.